Pharmacoeconomic Comparison of Anaprazole and I...

By Melike Belenli Gümüş

July 2, 2024

Introduction Peptic ulcer disease (PUD) affects 5%–10% of the global po...
Tuberculosis Care in Indonesia: A Financial Analysis of Strategic Purchasing ...
Cost-Effectiveness of IDegAsp in Diabetes Management: Insights from ARISE Study
Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndro...
The Economic Benefits of Preventive Health Programs
Introducing GRACE for Patient-Centric Care
The Economic Burden of Knee Arthroplasty Revisions: A Cost Analysis from Türkiye
Advancing Pneumococcal Disease Prevention in Japan with PCV20
The Impact of Time Horizons on QALY Calculations in Healthcare
Making Better Choices in Diabetes Care With Multi-criteria Decision Making (M...
The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Appro...
Health equity insights for National Cancer Survivors Day
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making